These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15309680)

  • 21. Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.
    Jamshidi Y; Flavell DM; Hawe E; MacCallum PK; Meade TW; Humphries SE
    Atherosclerosis; 2002 Jul; 163(1):183-92. PubMed ID: 12048138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass.
    Memisoglu A; Hu FB; Hankinson SE; Manson JE; De Vivo I; Willett WC; Hunter DJ
    Hum Mol Genet; 2003 Nov; 12(22):2923-9. PubMed ID: 14506127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PPARα polymorphisms as risk factors for dyslipidemia in a Brazilian population.
    Mazzotti DR; Singulane CC; Ota VK; Rodrigues TP; Furuya TK; de Souza FJ; Cordeiro BG; Magalhães C; Chen ES; Jacomini A; Smith Mde A; Borsatto-Galera B
    Mol Genet Metab; 2011 Feb; 102(2):189-93. PubMed ID: 21159535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gene-gene interactions among the peroxisome proliferator-activated receptor polymorphisms for hypertriglyceridemia].
    Gu SJ; Liu MM; Guo ZR; Wu M; Chen Q; Zhou ZY; Yu H; Zhang LJ; Luo WS
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Oct; 46(10):916-21. PubMed ID: 23363867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene-diet interactions and plasma lipoproteins: role of apolipoprotein E and habitual saturated fat intake.
    Campos H; D'Agostino M; Ordovás JM
    Genet Epidemiol; 2001 Jan; 20(1):117-128. PubMed ID: 11119301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the PPAR-Alpha L162V polymorphism on the cardiovascular disease risk factor in response to n-3 polyunsaturated fatty acids.
    Caron-Dorval D; Paquet P; Paradis AM; Rudkowska I; Lemieux S; Couture P; Vohl MC
    J Nutrigenet Nutrigenomics; 2008; 1(4):205-12. PubMed ID: 19776627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT).
    Tai ES; Collins D; Robins SJ; O'Connor JJ; Bloomfield HE; Ordovas JM; Schaefer EJ; Brousseau ME
    Atherosclerosis; 2006 Jul; 187(1):153-60. PubMed ID: 16221474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Features of the metabolic syndrome are modulated by an interaction between the peroxisome proliferator-activated receptor-delta -87T>C polymorphism and dietary fat in French-Canadians.
    Robitaille J; Gaudet D; Pérusse L; Vohl MC
    Int J Obes (Lond); 2007 Mar; 31(3):411-7. PubMed ID: 16953259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of common gene-smoking interactions with elevated plasma apolipoprotein B concentration.
    Roy N; Gaudet D; Tremblay G; Brisson D
    Lipids Health Dis; 2020 May; 19(1):98. PubMed ID: 32430061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome.
    Ambye L; Rasmussen S; Fenger M; Jørgensen T; Borch-Johnsen K; Madsbad S; Urhammer SA
    Diabetes Res Clin Pract; 2005 Feb; 67(2):175-9. PubMed ID: 15649578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population prevalence of APOE, APOC3 and PPAR-alpha mutations associated to hypertriglyceridemia in French Canadians.
    Garenc C; Aubert S; Laroche J; Girouard J; Vohl MC; Bergeron J; Rousseau F; Julien P
    J Hum Genet; 2004; 49(12):691-700. PubMed ID: 15549499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    Am Heart J; 2004 Jun; 147(6):1117-24. PubMed ID: 15199365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of polymorphism (RFLP-sstI) at the apolipoprotein C-III gene locus on the lipoprotein metabolism and insulin resistance in essential hypertensive patients. Interaction between gender and genetic polymorphism.
    Espino-Montoro A; Barrios-Artillo M; López-Chozas JM; Cayuela A; Stiefel P; Villar J
    Nutr Metab Cardiovasc Dis; 2003 Aug; 13(4):194-201. PubMed ID: 14650351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease.
    Flavell DM; Jamshidi Y; Hawe E; Pineda Torra I; Taskinen MR; Frick MH; Nieminen MS; Kesäniemi YA; Pasternack A; Staels B; Miller G; Humphries SE; Talmud PJ; Syvänne M
    Circulation; 2002 Mar; 105(12):1440-5. PubMed ID: 11914252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men.
    Skogsberg J; Kannisto K; Cassel TN; Hamsten A; Eriksson P; Ehrenborg E
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):637-43. PubMed ID: 12615676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diet and waist-to-hip ratio: important predictors of lipoprotein levels in sedentary and active young men with no evidence of cardiovascular disease.
    Mansfield E; McPherson R; Koski KG
    J Am Diet Assoc; 1999 Nov; 99(11):1373-9. PubMed ID: 10570674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate.
    Brouillette C; Bossé Y; Pérusse L; Gaudet D; Vohl MC
    J Hum Genet; 2004; 49(8):424-432. PubMed ID: 15249972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPAR-alpha L162V polymorphism in human hepatocellular carcinoma.
    Koytak ES; Mizrak D; Bektaş M; Verdi H; Arslan Ergül A; Idilman R; Cinar K; Yurdaydin C; Ersõz S; Karayalçin K; Uzunalimoğlu O; Bozkaya H
    Turk J Gastroenterol; 2008 Dec; 19(4):245-9. PubMed ID: 19119483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPARα-L162V polymorphism is not associated with schizophrenia risk in a Croatian population.
    Nadalin S; Giacometti J; Buretić-Tomljanović A
    Prostaglandins Leukot Essent Fatty Acids; 2014 Nov; 91(5):221-5. PubMed ID: 25087592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOE genotype associates with food consumption and body composition to predict dyslipidaemia in Brazilian adults with normal-weight obesity syndrome.
    Franco LP; Gonçalves Zardini Silveira A; Sobral de Assis Vasconcelos Lima R; Horst MA; Cominetti C
    Clin Nutr; 2018 Oct; 37(5):1722-1727. PubMed ID: 28720344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.